PharmEasy to acquire 66% stake in Thyrocare Tech for Rs 4,546 Cr

What is the news?

PharmEasy’s parent company API Holdings has signed final paperwork acquiring a 66.1 percent ownership in the Thyrocare Technologies Pvt Ltd from Dr. A Velumani and affiliates, for a price of Rs 1,300 each share, totaling Rs. 4.546 Cr. The acquisition is subject to regulatory and other customary approvals required.

Further information

“We are thrilled to be collaborating with Thyrocare,” stated Siddharth Shah, CEO of API Holdings. We deliver a world-class diagnostic customer experience, rivaling our pharmaceutical experience with technological leverage and creating Thyrocare in a large-scale and truly pan-Indian presence. Our goal is to offer all ambulatory health goods and services within 24 hours to every Indian.”